Vcanbio Cell & Gene ...
SHSE:600645
¥ 31,88
+ ¥1,11 (3,61%)
31,88 ¥
+¥1,11 (3,61%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥0,26
Earnings Per Share
¥3,48
Revenue Per Share
68,60%
Gross Margin %
¥14,53 B
Market Cap
¥0,01 B
Long-Term Debt
Earnings Per Share
¥0,26
Revenue Per Share
¥3,48
Gross Margin %
68,60%
Market Cap
¥14,53 B
Long-Term Debt
¥0,01 B

Financials

Year Year 2024 2023 2020 2015
EPS Earnings Per Share ¥0,22 ¥0,23 ¥-0,27 ¥0,54
Earnings Earnings ¥100,30M ¥107,63M ¥-126,35M ¥215,15M
RPS Revenue Per Share ¥3,48 ¥3,40 ¥0,00 ¥1,78
Revenue Revenue ¥1,59B ¥1,59B ¥0,00M ¥708,99M
OCF Operating Cash Flow ¥285,19M ¥0,00M ¥0,00M ¥8,17M
FCF Free Cash Flow ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OM Operating Margin 10,29% 8,69% 7,09% 14,50%
GM % Gross Margin % 68,60% 68,23% 65,80% 65,40%
FCFS Free Cash Flow Per Share ¥0,48 ¥0,45 ¥0,32 ¥-0,31
LT Debt Long-Term Debt N/A N/A N/A N/A
Sha. Stocks 455,9M 467,95M 467,95M 398,43M
×